Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, AutologousTransplantation, HomologousGranulocyte Colony-Stimulating FactorHematopoietic Stem Cell MobilizationTransplantation ConditioningCombined Modality TherapyAntineoplastic Combined Chemotherapy ProtocolsStem Cell TransplantationCyclophosphamideAntigens, CD34Hematologic NeoplasmsGraft vs Host DiseaseLeukapheresisTreatment OutcomeBone Marrow TransplantationMelphalanBlood Component RemovalGraft SurvivalLymphoma, Non-HodgkinHematopoietic Stem CellsBusulfanMultiple MyelomaMyeloablative AgonistsCord Blood Stem Cell TransplantationTransplantation ChimeraStem CellsTissue DonorsRecurrenceEtoposideSalvage TherapyAntineoplastic AgentsLiver TransplantationAntineoplastic Agents, AlkylatingRemission InductionHistocompatibilityThiotepaDisease-Free SurvivalWhole-Body IrradiationHistocompatibility TestingImmunosuppressive AgentsPOEMS SyndromeTransplantation, IsogeneicRetrospective StudiesSurvival RateInfectionSurvival AnalysisVidarabineLeukemiaTime FactorsIfosfamideHematopoiesisKidney TransplantationCytarabineAmyloidosisCarmustineHodgkin DiseaseBlood CellsVincristineLeukemia, Myeloid, AcuteGraft vs Leukemia EffectPlatelet CountDoxorubicinBlood Cell CountFollow-Up StudiesNeoplasmsMyelodysplastic SyndromesLymphomaCytomegalovirus InfectionsAnemia, AplasticChemotherapy, AdjuvantLymphocyte DepletionFatal OutcomeLeukemia, Myelogenous, Chronic, BCR-ABL PositiveFeasibility StudiesHematologic DiseasesCyclosporineCytophagocytosisImmunosuppressionPrecursor Cell Lymphoblastic Leukemia-LymphomaProspective StudiesBone MarrowTransplantation ImmunologyOpportunistic InfectionsHeart TransplantationHLA AntigensCell TransplantationPrognosisHistiocytosis, Non-Langerhans-CellBlood DonorsMesenchymal Stem Cell TransplantationLivedo ReticularisCarboplatinImmunophenotypingRecombinant ProteinsLung TransplantationBone Marrow PurgingPilot ProjectsMethotrexate